physician relationships

By Elio Evangelista, Director of Research As two of the major roles of medical science liaisons (MSLs), identifying influential physicians and building relationships with those thought leaders occupy more time than other activities. The actual amount...

By Elio Evangelista, Director of Research The United States is still waiting for the Centers for Medicare and Medicaid Services (CMS) to issue its final ruling on how it will implement the disclosure rules outlined in the Physician Payments Sunshine...

Cutting Edge Information's new customizable "MSL Data Suite" combines the company's experience in researching medical science liaison performance and MSL program management with our team's strength in providing Life Science companies with benchmarking data, analysis...

By Yanis Saradjian,Director of Consulting Our newly updated Fair-Market Value Benchmarking and Analysis service now provides medical, scientific and regulatory staff at life sciences companies with fair-market value benchmarks for thought leaders and influential...

By Casey Ferrell,Research Analyst Joining the ever-growing list of organizations, associations and trade groups to weigh in on social media, the American Medical Association this week adopted a non-binding policy suggesting how physicians should go about...

Six Tips to Help Build the Ideal Thought Leader Database As the industry awaits the release of the delayed Sunshine Act guidelines, pharmaceutical and medical device companies are benefiting from the extra time by reviewing current physician payment reporting...

This is the first blog entry in a two-part series on journal selection. By Ryan McGuire,Senior Research Analyst Evaluating the medical journal landscape is the first step toward making sure manuscripts find their way to the appropriate home. In fact,...

New study provides process for calculating compliant fair-market value payments Although 100 percent of drug companies compensate key opinion leaders (KOLs) for their method of travel, only 60 percent do so for any preliminary work. And as mandatory public...

Over Half of Drug Companies Now Use Electronic or Web-Based Tools for Managing Proposals Electronic or web-based submission systems for investigator initiated trial (IIT) proposals are now in place at 58% of biopharmaceutical companies, and that number is expected...

New Report Analyzes Return-on-Investment for Various Drug Marketing Activities 'Provider support' and other physician assistance strategies show some of the strongest return-on-investment among pharmaceutical marketing activities.  These activities and programs...